A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study (Q34021572)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study |
scientific article |
Statements
1 reference
A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study (English)
1 reference
J Proietto
1 reference
A Rissanen
1 reference
J B Harp
1 reference
N Erondu
1 reference
Q Yu
1 reference
S Suryawanshi
1 reference
M E Jones
1 reference
A O Johnson-Levonas
1 reference
S B Heymsfield
1 reference
K D Kaufman
1 reference
J M Amatruda
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference